Healthcare - Biotechnology - NASDAQ - US
$ 8.69
-3.55 %
$ 1.01 B
Market Cap
-6.12
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
149.09%
EBIT
Estimate
53.67%
Net Income
Estimate
28.56%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Applied Therapeutics, Inc.
APLT has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart APLT
EBIT FORECAST
EBIT Forecast Chart APLT
NET INCOME FORECAST
Net Income Chart APLT